274 related articles for article (PubMed ID: 12518421)
21. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice.
Romics L; Dolganiuc A; Kodys K; Drechsler Y; Oak S; Velayudham A; Mandrekar P; Szabo G
Hepatology; 2004 Sep; 40(3):555-64. PubMed ID: 15349893
[TBL] [Abstract][Full Text] [Related]
22. Essential role of MD-2 in B-cell responses to lipopolysaccharide and Toll-like receptor 4 distribution.
Miyake K; Nagai Y; Akashi S; Nagafuku M; Ogata M; Kosugi A
J Endotoxin Res; 2002; 8(6):449-52. PubMed ID: 12697088
[TBL] [Abstract][Full Text] [Related]
23. Molecular basis for innate immune recognition of microbial components.
Kawasaki K; Nishijima M
Jpn J Infect Dis; 2001 Dec; 54(6):220-4. PubMed ID: 11862003
[TBL] [Abstract][Full Text] [Related]
24. Innate recognition of lipopolysaccharide by CD14 and toll-like receptor 4-MD-2: unique roles for MD-2.
Miyake K
Int Immunopharmacol; 2003 Jan; 3(1):119-28. PubMed ID: 12538042
[TBL] [Abstract][Full Text] [Related]
25. Toll-like receptor 4 expression levels determine the degree of LPS-susceptibility in mice.
Kalis C; Kanzler B; Lembo A; Poltorak A; Galanos C; Freudenberg MA
Eur J Immunol; 2003 Mar; 33(3):798-805. PubMed ID: 12616500
[TBL] [Abstract][Full Text] [Related]
26. The Toll-like receptor 4 region Glu24-Pro34 is critical for interaction with MD-2.
Nishitani C; Mitsuzawa H; Hyakushima N; Sano H; Matsushima N; Kuroki Y
Biochem Biophys Res Commun; 2005 Mar; 328(2):586-90. PubMed ID: 15694388
[TBL] [Abstract][Full Text] [Related]
27. Interaction of endotoxins with Toll-like receptor 4 correlates with their endotoxic potential and may explain the proinflammatory effect of Brucella spp. LPS.
Dueñas AI; Orduña A; Crespo MS; García-Rodríguez C
Int Immunol; 2004 Oct; 16(10):1467-75. PubMed ID: 15339879
[TBL] [Abstract][Full Text] [Related]
28. Toll-like receptors and other links between innate and acquired alloimmunity.
Goldstein DR
Curr Opin Immunol; 2004 Oct; 16(5):538-44. PubMed ID: 15341996
[TBL] [Abstract][Full Text] [Related]
29. [Toll type receptors: molecular bases of the relationship between innate and adaptation responses of the immune system].
Moreno C; Sánchez-Ibarrola A
Rev Med Univ Navarra; 2003; 47(3):29-33. PubMed ID: 14727572
[TBL] [Abstract][Full Text] [Related]
30. Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: relationship to tolerance.
Calvano JE; Agnese DM; Um JY; Goshima M; Singhal R; Coyle SM; Reddell MT; Kumar A; Calvano SE; Lowry SF
Shock; 2003 Nov; 20(5):415-9. PubMed ID: 14560104
[TBL] [Abstract][Full Text] [Related]
31. CD40-mediated up-regulation of Toll-like receptor 4-MD2 complex on the surface of murine dendritic cells.
Frleta D; Noelle RJ; Wade WF
J Leukoc Biol; 2003 Dec; 74(6):1064-73. PubMed ID: 12960264
[TBL] [Abstract][Full Text] [Related]
32. [Relationships between LPS-tolerance and TLR4 as well as its signaling pathway].
Zhang DM; Mao BL
Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):277-9. PubMed ID: 14628483
[No Abstract] [Full Text] [Related]
33. Identification of mouse MD-2 residues important for forming the cell surface TLR4-MD-2 complex recognized by anti-TLR4-MD-2 antibodies, and for conferring LPS and taxol responsiveness on mouse TLR4 by alanine-scanning mutagenesis.
Kawasaki K; Nogawa H; Nishijima M
J Immunol; 2003 Jan; 170(1):413-20. PubMed ID: 12496426
[TBL] [Abstract][Full Text] [Related]
34. MD-2 is required for the full responsiveness of mast cells to LPS but not to PGN.
Ushio H; Nakao A; Supajatura V; Miyake K; Okumura K; Ogawa H
Biochem Biophys Res Commun; 2004 Oct; 323(2):491-8. PubMed ID: 15369778
[TBL] [Abstract][Full Text] [Related]
35. LPS in microbial pathogenesis: promise and fulfilment.
Beutler B
J Endotoxin Res; 2002; 8(5):329-35. PubMed ID: 12537691
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of TLR-4/MD-2 signaling by RP105/MD-1.
Divanovic S; Trompette A; Atabani SF; Madan R; Golenbock DT; Visintin A; Finberg RW; Tarakhovsky A; Vogel SN; Belkaid Y; Kurt-Jones EA; Karp CL
J Endotoxin Res; 2005; 11(6):363-8. PubMed ID: 16303092
[TBL] [Abstract][Full Text] [Related]
37. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4.
Shimazu R; Akashi S; Ogata H; Nagai Y; Fukudome K; Miyake K; Kimoto M
J Exp Med; 1999 Jun; 189(11):1777-82. PubMed ID: 10359581
[TBL] [Abstract][Full Text] [Related]
38. The p50-homodimer mechanism in tolerance to LPS.
Ziegler-Heitbrock L
J Endotoxin Res; 2001; 7(3):219-22. PubMed ID: 11581573
[No Abstract] [Full Text] [Related]
39. The amino-terminal region of toll-like receptor 4 is essential for binding to MD-2 and receptor translocation to the cell surface.
Fujimoto T; Yamazaki S; Eto-Kimura A; Takeshige K; Muta T
J Biol Chem; 2004 Nov; 279(46):47431-7. PubMed ID: 15337750
[TBL] [Abstract][Full Text] [Related]
40. The dynamics of LPS recognition: complex orchestration of multiple receptors.
Triantafilou M; Triantafilou K
J Endotoxin Res; 2005; 11(1):5-11. PubMed ID: 15826372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
